Related Experiment Video
Updated: Jan 22, 2026

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery
Published on: February 20, 2017
A Rare Pulmonary Artery Sarcoma Masquerading as Pulmonary Embolus
Rohen Skiba1, Nikki Stamp2, Molly Kehoe2
1Bendat Respiratory Research and Development Fund, St John of God Healthcare, Subiaco, Western Australia, Australia; Department of Cardiothoracic Surgery and Transplantation, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
A rare pulmonary artery sarcoma caused a patient's worsening cardiorespiratory function, mimicking multiple pulmonary emboli. Surgical debulking and chemotherapy offered stable disease at 9 months, improving prognosis for this aggressive cancer.
Area of Science:
- Cardiovascular Medicine
- Oncology
- Pulmonary Medicine
Background:
- Pulmonary artery sarcoma is a rare malignancy often presenting with symptoms mimicking pulmonary embolism.
- Early diagnosis and intervention are crucial due to the typically advanced stage at presentation and poor prognosis.
Observation:
- A 46-year-old woman presented with deteriorating cardiorespiratory function, presumed to be multiple unprovoked pulmonary emboli.
- Surgical intervention revealed an intimal soft tissue lesion in the right pulmonary artery, later diagnosed as sarcoma.
Findings:
- Pulmonary artery sarcoma can cause significant pulmonary vascular obstruction and right-sided heart strain.
- Surgical debulking is essential for improving ventilation-perfusion mismatching and relieving cardiac strain.
- Adjuvant chemoradiotherapy may improve median survival, with a median of 20 months reported.
Implications:
- This case highlights the importance of considering rare neoplasms in the differential diagnosis of unexplained pulmonary vascular obstruction.
- Aggressive surgical management combined with adjuvant therapy can lead to stable disease and potentially improved outcomes in pulmonary artery sarcoma.
- Further research into novel therapeutic strategies is warranted for this challenging malignancy.
More Related Videos
10:03Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
07:02A Large Animal Model for Pulmonary Hypertension and Right Ventricular Failure: Left Pulmonary Artery Ligation and Progressive Main Pulmonary Artery Banding in Sheep
Published on: July 15, 2021
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...